Nachrichten zur ASTRAZENECA DL-,25 SP.ADR Aktie

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm – AZN

NEW YORK, Feb. 09, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in AstraZeneca PLC ("AstraZeneca"…

FTSE 100 down 18 points L&G surges on Meji Yasuda deal House prices hit record in January 8.09am: FTSE 100…

A fresh earnings release was the news development powering AstraZenecas (NASDAQ: AZN) share price higher on Thursday. Investors were clearly…

AZN earnings call for the period ending December 31, 2024.…

AstraZeneca reports mixed results in the fourth quarter. It gains in pre-market after assuring investors that the business impact of…

CAMBRIDGE (dpa-AFX) - Der Pharmakonzern Astrazeneca hat sich dank eines überraschend starken Schlussspurts im vergangenen Jahr besser geschlagen als…

…

FTSE 100 jumps 122 points, sets record at 8,767 BoE cuts interest by 0.25% to 4.50% AstraZeneca surges on earnings beat 3.01pm:…

FTSE 100 jumps 131 points, sets record at 8,767 BoE cuts interest by 0.25% to 4.50% AstraZeneca surges on earnings beat 2.14pm:…